More News

20 Jun 2007 Organon's once-a-month contraceptive ring,NuvaRing® completes European authorization
20 Jun 2007 DeveloGen and Teva Enter into Exclusive License Agreement for DeveloGen’s Protein Kinase B Technology for the Treatment of Cancer
20 Jun 2007 Imaging Agent from Avid Radiopharmaceuticals to Be Licensed by Bayer Schering Pharma for Early Detection of Alzheimer's Disease
20 Jun 2007 Myriad Genetics Collaborates With AstraZeneca on Phase 2 Trials
19 Jun 2007 Kensey Nash Announces Results of EU Coronary Study Using the Thromcat(TM) Thrombectomy Catheter System
16 Jun 2007 Aurobindo gets USFDA Approval for Trandolapril Tablets
15 Jun 2007 BioSyntech reaches significant BST-CarGel(R) clinical milestone
15 Jun 2007 BioSyntech reaches significant BST-CarGel(R) clinical milestone
15 Jun 2007 Lupin Pharmaceuticals, Inc. Announces Final Approval of Trandolapril Tablets
14 Jun 2007 Lifecell Corporation receives 510(k) clearance for tissue repair product
14 Jun 2007 Lifecell Corporation receives 510(k) clearance for tissue repair product
14 Jun 2007 Watson Receives FDA Final Approval for Generic Wellbutrin XL(R) 300 Mg
13 Jun 2007 IBPL Becomes Country's First Dedicated Biopharmaceutical Facility to Receive EU-GMP Certification
13 Jun 2007 Favrille Acquires Anti-CD20 Monoclonal Antibodies from Diversa
13 Jun 2007 Novo Nordisk opens new pilot plant for biopharmaceutical products in Hillerod, Denmark
13 Jun 2007 Penwest Begins Dosing Phase IIa Clinical Study of Nalbuphine ER
13 Jun 2007 Kissei and Eisai sign a license agreement to develop and commercialize Glufast(R), a rapid-acting insulin secretagogue in 10 ASEAN countries
13 Jun 2007 CombinatoRx and Angiotech Extend Research and Development Collaboration to Create Next Generation Drug Device and Local Delivery Medicines
13 Jun 2007 CombinatoRx and Angiotech Extend Research and Development Collaboration to Create Next Generation Drug Device and Local Delivery Medicines
12 Jun 2007 Merck Signs Strategic Alliance With Archemix
12 Jun 2007 Biotec Pharmacon enters Phase III with the diabetic ulcers indication
12 Jun 2007 NEOPHARM, Inc. Signs Exclusive License Agreement for the Use of CINTREDEKIN BESUDOTOX (IL13-PE38QQR) for the Treatment of Pulmonary Fibrosis and Asthma
12 Jun 2007 Kurve Technology and Schering-Plough Sign Expanded Technology Agreement
12 Jun 2007 Kurve Technology and Schering-Plough Sign Expanded Technology Agreement
12 Jun 2007 Archemix and Takeda to Enter into Collaboration for

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2017 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up
Top